Nathan Brown

Nathan is the Head of Chemoinformatics at an innovative artificial intelligence and drug discovery startup in London, called BenevolentAI. Recognised as a global thought-leader in Chemoinformatics and computational drug discovery, Nathan is the inventor of the first multiobjective de novo molecular design system. From 2007 until 2017, he was at the Institute of Cancer Research, London where he founded and led the In Silico Medicinal Chemistry team for over ten years, with significant research impact on pre-clinical and clinical candidates, and the development of new algorithms for drug discovery. Nathan has published over 40 papers and three books; is a Fellow of The Royal Society of Chemistry; and is the 2017 recipient of the Corwin Hansch Award.